Sanofi US announces collaborations with DCRI and CATCH
The collaborations will create tools to predict how type 2 diabetics will follow their medication plans. Read More »
NACDS applauds access to pharmacy services provision in CMS final rule
CMS included pharmacies as key providers in the Medicaid and CHIP Managed Care final rule. Read More »
Cigna commits $2 million to World of Difference grants
Nonprofit partners providing Community Health Navigation will be a priority when awarding the grants. Read More »
APhA supports National Prescription Drug Take Back Day Initiative
Consumers can safely dispose of unused prescription drugs during National Prescription Drug Take Back Day. Read More »
NACDS annual meeting builds relationships
The annual conference allows executives from retailers, suppliers and other health care providers an opportunity to network and build relationships. Read More »
Oasmia announces positive Phase III results in ovarian cancer treatment
Overall survival rates positive in the Phase III study of epithelial ovarian cancer treatment. Read More »
Allergan announces presentations at the ARVO annual meeting
Allergan to present results of its studies at the ARVO meeting next week. Read More »
Pfizer announces SPIRE-2 clinical trial is full
The clinical trial will test bococizumab versus a placebo in reducing the risk of a major cardiovascular event. Read More »
Prime supports CRSxP roadmap for affordable prescription drugs
CSRxP announces its policy platform to address rising prescription drug prices. Read More »
AstraZeneca and Ironwood announce licensing agreement for Zurampic
Zurampic has been approved by the FDA for treatment of hyperuricemia associated with gout. Read More »
Proposed amendment to drug plan bill could spike costs for Oklahoma consumers, says national healthcare expert
Oklahoma consumers enrolled in health plans with insurance deductibles that are yet to be reached and those who are uninsured may bear the high costs of rising drug prices, thanks to a proposed piece of legislation that would give pharmacies permission to disregard negotiated discounts with insurers and transfer the price hikes on to consumers. Read More »
Pfizer announces CHANTIX/CHAMPIX results in largest trial of smoking cessation medications
CHANTIX/CHAMPIX compared to bupropion, nicotine patch and placebo; study finds significantly higher abstention rates. Read More »
Prime pharmacists recognized by Academy of Managed Care Pharmacy
AMCP recognizes Prime pharmacists with Fellow and New Practitioner awards. Read More »
CVS Pharmacy's MinuteClinics now open in Chicago area Target stores
Thirteen rebranded MinuteClinics are now open inside Target stores in Chicago and surrounding areas. Read More »
CVS announces voluntary recall of herbal tea
Gold Emblem Abound Organic Spiced Herbal Tea recalled due to potential contamination with Salmonella. Read More »
AstraZeneca to incorporate genomics in its research and development
AstraZeneca and its R&D arm, MedImmune, announced its integrated genomics initiative this week. Read More »
Meijer to add in-store clinics in Wisconsin and Michigan
New in-store clinics to open in Waukesha and Sussex, WI, and Lansing, MI. Read More »
Allergan plc acquires Topokine Therapeutics for $85 million
Topokine is focused on topical medications to reduce fat; Allergen acquires XAF5 in the purchase. Read More »
Paws for Veterans receives nearly $12,000 from APhA
APhA raised nearly $12,000 during its 2016 annual meeting and expo in March. Read More »
Results of two diabetes studies announced by Prime Therapeutics
Studies found that insulin usage and costs increased; ER visits related to hypoglycemia infrequent. Read More »
Alerts Sign-up